COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Influenza Vaccine Postpartum Questionnaire

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00401700
Recruitment Status : Completed
First Posted : November 20, 2006
Last Update Posted : February 22, 2019
Information provided by (Responsible Party):
St. Michael's Hospital, Toronto

Brief Summary:
The purpose of this trial is to assess the knowledge and attitudes of post-partum women regarding influenza and the use of the influenza vaccine in pregnancy.

Condition or disease
Influenza Vaccine Pregnancy

Detailed Description:
Women on our post-partum floor will be approached to complete a questionnaire which will assess their knowledge and attitudes regarding influenza and the use of the influenza vaccine in pregnancy. The study will take place over a 2-month period during influenza season, and at the time when the influenza vaccine becomes available.

Layout table for study information
Study Type : Observational
Actual Enrollment : 150 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Acceptability and Feasibility of Influenza Vaccine Administration on the Post-partum Floor Prior to Discharge Home During Flu Season
Study Start Date : October 2006
Actual Primary Completion Date : January 2008
Actual Study Completion Date : July 2009

Resource links provided by the National Library of Medicine

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
pregnant women

Inclusion Criteria:

  • women admitted to the postpartum floor during the study period

Exclusion Criteria:

  • inability to read or understand English

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00401700

Layout table for location information
Canada, Ontario
St. Michael's Hospital
Toronto, Ontario, Canada, M5B 1W8
Sponsors and Collaborators
St. Michael's Hospital, Toronto
Layout table for investigator information
Principal Investigator: Mark H Yudin, MD, MSc St. Michael's Hospital (Toronto, Canada)
Layout table for additonal information
Responsible Party: St. Michael's Hospital, Toronto Identifier: NCT00401700    
Other Study ID Numbers: 06-190
First Posted: November 20, 2006    Key Record Dates
Last Update Posted: February 22, 2019
Last Verified: February 2019
Keywords provided by St. Michael's Hospital, Toronto:
influenza vaccine
Additional relevant MeSH terms:
Layout table for MeSH terms
Influenza, Human
Orthomyxoviridae Infections
RNA Virus Infections
Virus Diseases
Respiratory Tract Infections
Respiratory Tract Diseases